HCV/Sindbis chimeric viruses to study the NS3 protease of hepatitis C virus in living cells

被引：0

作者：

Filocamo, G ^{[1
]}

Pacini, L ^{[1
]}

Migliaccio, G ^{[1
]}

机构：

[1] IRBM P ANGELETTI,ROME,ITALY

来源：

MOLECULAR BIOLOGY OF THE CELL | 1996年 / 7卷

关键词：

D O I：

暂无

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

引用

页码：3460 / 3460

页数：1

共 50 条

[41] Novel, sulfonamide linked inhibitors of the hepatitis C virus NS3 protease [J].

Kirschberg, Thorsten A. ;

Squires, Neil H. ;

Yang, Huiling ;

Corsa, Amoreena C. ;

Tian, Yang ;

Tirunagari, Neeraj ;

Sheng, X. Christopher ;

Kim, Choung U. .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (03) :969-972

[42] Molecular docking of peptide inhibitors to the hepatitis C virus NS3 protease [J].

Shenderovich, M ;

Wang, J ;

Fisher, C ;

Ramnarayan, K ;

Abagyan, R .

PEPTIDES FOR THE NEW MILLENNIUM, 2000, :472-473

[43] Computational Approaches to Study Peptidomimetic and Macrocyclic Hepatitis C Virus NS3 Protease Inhibitors [J].

Ezat, Ahmed A. ;

Mostafa, Hamdy I. ;

El-Bialy, Nihal. S. ;

Saleh, Noha A. ;

Ibrahim, Medhat A. .

JOURNAL OF COMPUTATIONAL AND THEORETICAL NANOSCIENCE, 2015, 12 (01) :52-59

[44] Resistance Analysis of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir [J].

McPhee, Fiona ;

Friborg, Jacques ;

Levine, Steven ;

Chen, Chaoqun ;

Falk, Paul ;

Yu, Fei ;

Hernandez, Dennis ;

Lee, Min S. ;

Chaniewski, Susan ;

Sheaffer, Amy K. ;

Pasquinelli, Claudio .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (07) :3670-3681

[45] Novel tripeptide inhibitors of hepatitis C virus NS3 serine protease [J].

不详 .

EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (02) :267-272

[46] Hepatitis C virus NS2 is a protease stimulated by cofactor domains in NS3 [J].

Schregel, V. ;

Jacobi, S. ;

Penin, F. ;

Tautz, N. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (13) :5342-5347

[47] Evolutionary dynamics of hepatitis C virus NS3 protease domain during and following treatment with narlaprevir, a potent NS3 protease inhibitor [J].

de Bruijne, J. ;

Thomas, X. V. ;

Rebers, S. P. ;

Weegink, C. J. ;

Treitel, M. A. ;

Hughes, E. ;

Bergmann, J. F. ;

de Knegt, R. J. ;

Janssen, H. L. A. ;

Reesink, H. W. ;

Molenkamp, R. ;

Schinkel, J. .

JOURNAL OF VIRAL HEPATITIS, 2013, 20 (11) :779-789

[48] Novel potent inhibitors of hepatitis C virus (HCV) NS3 protease with cyclic sulfonyl P3 cappings [J].

Chen, Kevin X. ;

Vibulbhan, Bancha ;

Yang, Weiying ;

Nair, Latha G. ;

Tong, Xiao ;

Cheng, Kuo-Chi ;

Njoroge, F. George .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (04) :1105-1109

[49] Serine protease of hepatitis C virus expressed in insect cells as the NS3/4A complex [J].

Sali, DL ;

Ingram, R ;

Wendel, M ;

Gupta, D ;

McNemar, C ;

Tsarbopoulos, A ;

Chen, JW ;

Hong, Z ;

Chase, R ;

Risano, C ;

Zhang, RM ;

Yao, NH ;

Kwong, AD ;

Ramanathan, L ;

Le, HV ;

Weber, PC .

BIOCHEMISTRY, 1998, 37 (10) :3392-3401

[50] Discovery and development of Boceprevir, an HCV NS3 protease inhibitor, for the treatment of hepatitis C infection [J].

Howe, Anita .

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243

← 1 2 3 4 5 →